
# Title 40 - Protection of Environment
## Chapter I - Environmental Protection Agency
### Subchapter R - Toxic Substances Control Act
#### PART 795 - PROVISIONAL TEST GUIDELINES
##### Subpart D - Provisional Health Effects Guidelines
###### ยง 795.225 Dermal pharmacokinetics of DGBE and DGBA.
####### Test report.

(3)In addition to the reporting requirements as specified in the TSCA Good Laboratory Practice Standards, in part 792, subpart J of this chapter, the following specific information shall be reported:

(i) Species, strain, and supplier of laboratory animals.

(ii) Information on the degree (i.e., specific activity for a radiolabel) and sites of labeling of the test substances.

(iii) A full description of the sensitivity and precision of all procedures used to produce the data.

(iv) Relative percent absorption by the dermal route for rats administered low and high doses ofC-DGBE andC-DGBA.

(v) Quantity of isotope, together with percent recovery of the administered dose, in feces and urine.

(vi) Biotransformation pathways and quantities of DGBE and metabolites in urine collected after administering single high and low dermal doses to rats.
